arsenic trioxide has been researched along with Cirrhosis, Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, J; Hu, Y; Li, S; Niu, Q; Song, G; Wang, H | 1 |
| Nithyananthan, S; Thirunavukkarasu, C | 1 |
| Chen, H; Liu, J; Liu, L; Liu, M; Shi, B; Ye, L; Yu, L; Zhang, Y | 1 |
3 other study(ies) available for arsenic trioxide and Cirrhosis, Liver
| Article | Year |
|---|---|
Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
Topics: Arsenic Trioxide; Cell Survival; Cells, Cultured; Gene Silencing; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Nuclear Proteins; Promyelocytic Leukemia Protein; Sumoylation; Transcription Factors; Ubiquitin-Conjugating Enzymes | 2020 |
Arsenic trioxide, a cancer chemo drug hampers fibrotic liver regeneration by interrupting oxidative stress rekindling and stellate cell rejuvenation.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Hepatic Stellate Cells; Liver Cirrhosis; Liver Regeneration; Male; Oxidative Stress; Rats; Rats, Wistar | 2020 |
A case report of acute myeloid leukemia after liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabine; Daunorubicin; Hepatitis B; Humans; Leukemia, Myeloid, Acute; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mitoxantrone; Oxides; Tretinoin | 2013 |